ORDER OF NATIONAL MEDICAL INSURANCE COMPANY OF THE REPUBLIC OF MOLDOVA

of August 11, 2022 No. 776/188-A

About introduction of amendments to the Order of the Minister of Health and the CEO of National medical insurance company No. 605/133-A of June 21, 2022 "About the medicines and medical products compensated from funds of compulsory medical insurance"

Based on Item 2 of the Regulations on appointment and leave of the compensated drugs and medical products for treatment in out-patient conditions of persons registered at the family doctor approved by the Order of the Government No. 106/2022 (The official monitor of the Republic of Moldova, 2022, to Art. No. 61-67, 153), we ORDER:

1. The order of the Minister of Health and CEO of National medical insurance company No. 605/133-A of 21.06.2022 "About the medicines and medical products compensated from funds of compulsory medical insurance" (Official monitor of the Republic of Moldova, 2022, to change No. 186, the Art. 7182) registered in the Ministry of Justice at No. 1728 of June 21 2022, as follows:

1) in appendix No. 1:

a) in Chapter I, Section 1:

in Item 3 line item (BECLOMETASONUM to exclude 047);

in Item 5 line item (ISOSORBIDI DINITRAS to exclude 009);

b) in Chapter I, Section 2:

in Item 6 line item (THEOPHYLLINUM to exclude 045);

in Item 14 line item (GLIBENCLAMIDUM to exclude 702);

in Item 14 in line items (710 - 716) the text "The following doses and pharmaceutical forms are allowed to compensation" to replace with the text "Are allowed to compensation according to the contract retail price included in the KN List of the compensated medicines and dosage forms, the following doses and pharmaceutical forms:";

c) in Chapter II, Section 1:

TETRACICLINUM line item (861) for adults, (to exclude 204) for children;

Appendix No. 2 to state 2) in the following edition:

Appendix No. 2 (39Kb In original language)

Disclaimer! This text was translated by AI translator and is not a valid juridical document. No warranty. No claim. More info